Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis
The Lancet Neurology2016Vol. 16(1), pp. 55–65
Citations Over TimeTop 1% of 2016 papers
David J. Irwin, Murray Grossman, Daniel Weintraub, Howard I. Hurtig, John E. Duda, Sharon X. Xie, Edward B. Lee, Vivianna M. Van Deerlin, Oscar L. López, Julia Kofler, Peter T. Nelson, Gregory A. Jicha, Randy Woltjer, Joseph F. Quinn, Jeffrey Kaye, James B. Leverenz, Debby W. Tsuang, Katelan Longfellow, Dora Yearout, Walter A. Kukull, C. Dirk Keene, Thomas J. Montine, Cyrus P. Zabetian, John Q. Trojanowski
Related Papers
- → Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies(2020)449 cited
- → The structural differences between patient-derived α-synuclein strains dictate characteristics of Parkinson’s disease, multiple system atrophy and dementia with Lewy bodies(2020)281 cited
- → α‐Synuclein RT‐QuIC assay in cerebrospinal fluid of patients with dementia with Lewy bodies(2019)173 cited
- → GBA1 Gene Mutations in α-Synucleinopathies—Molecular Mechanisms Underlying Pathology and Their Clinical Significance(2023)37 cited
- → Lewy Body Dementias and Other Synucleinopathies(2018)